Top Story

Xolair effective, well tolerated in children aged younger than 12 years

February 27, 2015

HOUSTON — Xolair was well tolerated and significantly improved asthma control among children aged younger than 12 years, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

“Omalizumab is FDA approved for treatment of moderate to severe persistent allergic asthma in patients aged 12 years and older who are not controlled by inhaled corticosteroids,” study researcher Sayantani B. Sindher, MD, of The Children’s Hospital of Philadelphia, and colleagues wrote. “There is limited data on its use in patients younger than 12 years.”

ACIP confirms recommendation for annual influenza vaccination

February 27, 2015
In a unanimous decision, the CDC’s Advisory Committee on Immunization Practices supported the recommendation that all people aged 6 months and older be vaccinated…
In the Journals

Chest CT imaging may safely be omitted from neuroblastoma surveillance for pediatric patients

February 27, 2015
Neuroblastoma progression or recurrence in the chest is rare among children and usually can be detected with non-CT imaging modalities or through the presentation of…
Meeting News Coverage

Breastfeeding duration may affect association between eczema risk, FLG variants

February 27, 2015
HOUSTON — Longer duration of breastfeeding weakened the association between filaggrin gene variants and eczema development in early years of life, according to…
Meeting News Coverage

Abbreviated ART noninferior to continuous ART in children with HIV

February 27, 2015
SEATTLE —Sustiva-based, first-line ART with “weekend breaks” was noninferior to continuous therapy in HIV-1 infected adolescents, demonstrating similar…
More News Headlines »
Guest Editorial

Childhood Epilepsy

Pediatric Annals, February 2015, Volume 44 Issue 2
More »
CME
Pediatric Annals December 2014

Sports Medicine: December 2014

Keck School of Medicine of USC and Pediatric Annals

The past two decades have witnessed an amazing increase in the participation in competitive sports by children of all…
More »
Meeting News Coverage Video
St. Jude/PIDS conference highlights new frontiers, career potential for infectious disease specialists

St. Jude/PIDS conference highlights new frontiers, career potential for infectious disease specialists

February 23, 2015
MEMPHIS, Tenn. — Elaine I. Tuomanen, MD, director of the Children’s Infection Defense Center at St. Jude…
More »
morganatic-roan